Primary Hyperparathyroidism: Effects on Bone Health

Endocrinol Metab Clin North Am. 2017 Mar;46(1):87-104. doi: 10.1016/j.ecl.2016.09.012. Epub 2016 Dec 14.

Abstract

Primary hyperparathyroidism (PHPT) is the most common cause of chronic hypercalcemia. With the advent of routine calcium screening, the classic presentation of renal and osseous symptoms has been largely replaced with mild, asymptomatic disease. In hypercalcemia caused by PHPT, serum parathyroid hormone levels are either high, or inappropriately normal. A single-gland adenoma is responsible for 80% of PHPT cases. Less frequent causes include 4-gland hyperplasia and parathyroid carcinoma. Diminished bone mineral density and nephrolithiasis are the major current clinical sequelae. Parathyroidectomy is the only definitive treatment for PHPT, and in experienced hands, cure rates approach 98%.

Keywords: Bone density; Hypercalcemia; Hyperparathyroidism; Osteoporosis; Parathyroid carcinoma; Parathyroid neoplasms.

Publication types

  • Review

MeSH terms

  • Bone Density
  • Bone and Bones / physiopathology*
  • Calcium / blood
  • Humans
  • Hypercalcemia / etiology
  • Hyperparathyroidism
  • Hyperparathyroidism, Primary / complications
  • Hyperparathyroidism, Primary / physiopathology*
  • Nephrolithiasis / complications
  • Parathyroid Hormone / blood
  • Parathyroid Neoplasms / complications
  • Parathyroidectomy

Substances

  • Parathyroid Hormone
  • Calcium